相关实验视频

Updated: Jan 10, 2026

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

使用CRISPR-Cas9编辑哈普罗型作为NEFL中主导负误解突变的治疗方法

Poorvi H Dua¹, Bazilco M J Simon², Chiara B E Marley¹

¹Department of Pediatrics, University of California, San Francisco, San Francisco, CA 94143, USA; Gladstone Institutes, San Francisco, CA 94158, USA.

Molecular therapy : the journal of the American Society of Gene Therapy

|November 21, 2025

概括

基因编辑可以使诸如Charcot-Marie-Tooth型2E (CMT2E) 等遗传疾病的主导疾病等位基因失活. 这项研究开发了一种类型编辑策略,以准多个NEFL突变,显示了更广泛的治疗应用的希望.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
神经科学是一个神经科学.

背景情况:

主导负遗传性疾病,如Charcot-Marie-Tooth型2E (CMT2E),是由单个基因拷贝中的突变引起的.
目前的等位基因特异性基因编辑策略面临的挑战是导致CMT2E的突变多样性.
神经纤维光 (NEFL) 基因突变是主要的神经退行性疾病的重要原因.

研究的目的:

开发和验证一种哈普洛型编辑方法,以准多个导致CMT2E的NEFL突变.
通过针对具有疾病等位基因的 cis 中的单核酸多态性来应对各种 NEFL 突变的挑战.
优化基因切除编辑并评估其在诱导多能干细胞 (iPSC) 衍生的运动神经元中的有效性.

主要方法:

通过CRISPR-Cas9利用等位基因特异性基因编辑来准与NEFL突变相关的单核酸多态.
采用诱导多能干细胞 (iPSC) 技术来获得运动神经元,用于疾病建模和测试.
开发了新的分子测试,以优化编辑效率,并分析基因编辑的副产品,如反转.

主要成果:

成功验证了具有不同NEFL误解突变的iPSC线条中的单双型编辑方法,证明了运动神经元中的表型救援.
鉴定出基因逆转,是切除编辑的常见副产品,无法可靠地使突变NEFL等位基因失活.
使用新的测试优化编辑策略,在不成熟的iPSC运动神经元中实现治疗编辑水平.

结论:

针对单核酸多态的哈普洛型编辑为CMT2E治疗提供了一种解决多个主导NEFL突变的策略.
基因逆转副产品需要在基因编辑策略中仔细监测和优化.
这种方法有可能为更广泛的患有主导遗传性疾病的患者群体开发治疗方法.

关键词:

克里斯普尔是什么意思?克里斯普尔是什么意思?查尔科特-玛丽-牙主导-负面的优势.切除术切除术是一种切除术.基因编辑基因编辑这就是 iPSC 的意义.逆转的反转方式运动神经元运动神经元这是一个神经纤维神经纤维.神经病变是一种神经病变.

更多相关视频

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...